Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With Post Traumatic Stress Disorder

NCT03667846 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03667846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With Post Traumatic Stress Disorder
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Recruiting
Start date
October 10, 2019
Completion date
August 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, post traumatic stress disorder